Receive our newsletter – data, insights and analysis delivered to you
Sponsored by Pharmaceutical Development Group

Drug Labeling Specialist on New Pregnancy Labeling Rules

Free White Paper

Drug Labeling Specialist on New Pregnancy Labeling Rules

By Pharmaceutical Development Group

Drug Labeling Specialist on New Pregnancy Labeling Rules

By Pharmaceutical Development Group
Enter your details to receive the free paper:

On 30 June, 2015, new pregnancy labeling rules for prescription drugs took effect, marking the demise of pregnancy categories (A, B, C, D, X), which have been in use since 1979.

The new rule ushers in what is expected to be an era of unprecedented inclusion with regard to descriptive risk and benefit information.

The US Food and Drug Administration (FDA) said: “a narrative structure for pregnancy labeling, rather than a category system, is best able to capture and convey the potential risks of drug exposure based on animal or human data, or both”.

Download this free whitepaper to find out more.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU